IMCAS World Congress 2025
Program

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: 1. Discuss inside and outside managment of aging
2. Discuss the importance of biologic age management
3. Present an AI assisted longevity program that can be easily implemented in clinical practice

Introduction: We are at the beginning of a revolution in the management of aging as an acquired and/or genetically determined "disease". In order to provide patients and customers with a means to improve longevity and wellness, a program was developed to assess biologic aging.

Materials / method: Patients are offered biologic age testing and genetic engineering consultation to address longevity. A simple but robust longevity program has been implemented. A finger stick, blood tests and uploaded medical history are performed.

Results: Patients are provided with a full report that includes their intrinsic and extrinsic biologic age, their rate of aging, their telomere length and how it compares to the general population among several other data points. In addition, "bespoke" supplements are constructed and a genetic engineer consults and recommends various biohacking manuevers. Results can be reassessed at one year and the regimens altered based on overall performance enhancement.

Conclusion: Longevity and wellness care has become an important component of addressing aesthetic patients from "inside-out". Aesthetic patients are a perfect population to introduce these concepts to. In the age of "Ozempic", in addition to managing muscle atrophy and loss of dermal white adipose tissue, biologic age management is easily integrated into current best practices in Aesthetic Medicine

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): co-founder, board member, shareholder, Mage Biotechnologies

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: Mage Biotechnology

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): SHQREHOLDER

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No
Please specify entities (individual, company, society): Abbvie

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: Abbvie

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability